Metraipolis › archive › dc_fdfb9aedac23

Subcutaneous MG1113 in severe hemophilia A and B: phase 1b study for safety, pharmacokinetics, and pharmacodynamics — Europe PMC PMID:42757060

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42757060
DOI
10.1016/j.rpth.2026.106910
License (as archived)
solo-consultazione
Archived
2026-10-08T03:48:39.943Z
SHA-256 of the archived text
10c8bf28c2d14689c69cd73e92beef19bf67ea73c0bee2fe7eb3a6531a6c3432
Stable URL of this page
https://metraipolis.com/documento/dc_fdfb9aedac23

How to cite

Subcutaneous MG1113 in severe hemophilia A and B: phase 1b study for safety, pharmacokinetics, and pharmacodynamics — Europe PMC PMID:42757060 — Europe PMC (en), https://europepmc.org/article/MED/42757060 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fdfb9aedac23 (Metraipolis archive dc_fdfb9aedac23, sha256 10c8bf28c2d14689c69cd73e92beef19bf67ea73c0bee2fe7eb3a6531a6c3432)
BibTeX
@misc{dcfdfb9aedac23,
  title = {Subcutaneous MG1113 in severe hemophilia A and B: phase 1b study for safety, pharmacokinetics, and pharmacodynamics — Europe PMC PMID:42757060},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42757060},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fdfb9aedac23; sha256 10c8bf28c2d14689c69cd73e92beef19bf67ea73c0bee2fe7eb3a6531a6c3432},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42757060. Agents can read the archived copy with the MCP tool read_document.